ABYA Genomics


Developer of a computational platform for designing, testing, and validating gene therapies using in silico methods. Describes capabilities in sequence analysis, protein structure prediction with machine learning, genomic visualization, genetic circuit engineering, and computational approaches to assess safety and efficacy that aim to reduce reliance on experimental clinical testing.

Industries

artificial-intelligence
bioinformatics
biotechnology
genetics
health-care
life-science

Nr. of Employees

small (1-50)

ABYA Genomics

San Francisco, California, United States, North America


Products

Sequence viewer for large FASTA files

A viewer and analysis tool capable of loading large FASTA files, searching for DNA sequence patterns, and performing sequence calculations on constrained hardware.


Services

An integrated software platform intended to design, test and validate gene therapies using computational methods and data analysis workflows.

Expertise Areas

  • In silico gene therapy design
  • Computational safety and efficacy assessment
  • Bioinformatics and genomic visualization
  • Machine learning for structural biology
  • Show More (3)

Key Technologies

  • In silico simulation and computational modeling
  • Machine learning for protein structure prediction
  • FASTA sequence analysis
  • Genomic visualization (dot plots, synteny detection)
  • Show More (4)

News & Updates

Publication of research sessions, development demos, and behind-the-scenes analyses via video and blog posts.

Company nomination in the Global Startup Awards in the category of Best AI-Enabled Startup.

Demonstrated a custom sequence viewer loading large FASTA files and performing DNA pattern searches on a 2002 Macintosh with 4GB RAM.

Developed and implemented an initial machine learning model to predict secondary protein structures from PDB data.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.